Emergent BioSolutions Inc (NYSE:EBS)

54.91
Delayed Data
As of Oct 18
 +0.74 / +1.37%
Today’s Change
39.11
Today|||52-Week Range
73.89
-7.37%
Year-to-Date

Today’s Trading

Previous close54.17
Today’s open53.99
Day’s range53.99 - 55.18
Volume274,494
Average volume (3 months)411,073
Market cap$2.8B
Data as of 6:30pm ET, 10/18/2019

Growth & Valuation

Earnings growth (last year)-36.79%
Earnings growth (this year)+31.38%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+39.50%
P/E ratioNM
Price/Sales3.89
Price/Book2.79

Competitors

 Today’s
change
Today’s
% change
IMMUImmunomedics Inc-0.42-2.65%
NKTRNektar Therapeutics-0.50-2.81%
IOVAIovance Biotherapeut...+0.12+0.62%
ALLOAllogene Therapeutic...-0.41-1.48%
Data as of 4:00pm ET, 10/18/2019

Financials

Next reporting dateNovember 6, 2019
EPS forecast (this quarter)$0.89
Annual revenue (last year)$782.4M
Annual profit (last year)$62.7M
Net profit margin8.01%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Gaithersburg, Maryland

Forecasts